NCT00006036View on ClinicalTrials.gov

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 22, 2000

Primary Completion Date

September 26, 2002

Study Completion Date

December 21, 2009

Conditions
Head and Neck CancerLung CancerOvarian CancerUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

cisplatin

DRUG

lurtotecan liposome

Trial Locations (3)

V5Z 4E6

British Columbia Cancer Agency, Vancouver

L8V 5C2

Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton

M5G 2C4

Toronto General Hospital, Toronto

Sponsors
All Listed Sponsors
lead

NCIC Clinical Trials Group

NETWORK